ISAB.ST Inhalation Sciences Sweden AB

Healthcare Real Estate Management & Development Stockholm Exchange
0.0810 SEK
Close of Nov 3, 2026
0.0470 0.6250
Market cap
SEK 4.15M
P/E
-
P/B
0.42x
ROE
-99.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is ISAB.ST undervalued?

Graham number

The Graham number of Inhalation Sciences Sweden AB cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Inhalation Sciences Sweden AB fundamental analysis

No fundamental analysis for Inhalation Sciences Sweden AB yet.

Inhalation Sciences Sweden AB stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Inhalation Sciences Sweden AB

Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research in Sweden. The company offers PreciseInhale, a laboratory system that allows scientists to measure how inhaled particles act in lungs and affect the health; DissolvIt, which enables in vitro simulation of dissolution and absorption of respirable particles in the lung epithelium; XposeALI, a 3D cell exposure module that combines aerosol capability with 3D cell models cultured at …

Full company profile